σ1receptorantagonist,approximately50-foldselectiveoverσ2sitesand≥100-foldselectiveoveropioid,PCP,muscarinic,dopamine,α1,α2,βadrenoceptor,5-HT1and5-HT2receptors.Preventshyperlocomotionfollowingcocaineadministrationinmice.
| M.Wt | 346.13 |
| Formula | C13H18Cl2N2.2HCl |
| Storage | StoreatRT |
| Purity | ≥99%(HPLC) |
| CASNumber | 206996-13-6 |
| PubChemID | 11617161 |
| InChIKey | NXFDBTLQOARIMH-UHFFFAOYSA-N |
| Smiles | Cl.Cl.CN1CCN(CCC2=CC=C(Cl)C(Cl)=C2)CC1 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| water | 34.61 | 100 |
Thefollowingdataisbasedontheproductmolecularweight346.13.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 2.89mL | 14.45mL | 28.89mL |
| 5mM | 0.58mL | 2.89mL | 5.78mL |
| 10mM | 0.29mL | 1.44mL | 2.89mL |
| 50mM | 0.06mL | 0.29mL | 0.58mL |



